Featured Neurosciences Videos |view more
A Penn pharmacist discusses Penn Medicine’s Multiple Sclerosis and Related Disorders Center.
Penn Medicine expert, Dr. Amit Bar-Or discusses the latest multiple sclerosis research at Penn Medicine’s Center for Neuroinflammation and Neurotherapeutics at the Perelman School of Medicine.
Providers discuss Penn Medicine’s Multiple Sclerosis and Related Disorders Center.
Amit Bar-Or, MD, FRCPC, Chief of the Multiple Sclerosis Division at Penn Medicine and Director of the Center for Neuroinflammation and Neurotherapeutics at the Perelman School of Medicine, discusses the latest multiple sclerosis research, ...
Featured Articles & Documents |view more
Advanced treatment for epilepsy can offer a unique look at the human mind from inside. Penn Medicine’s newest inpatient facility will bring research and clinical care closer together, helping to forge fundamental neuroscience discoveries ...
Penn Medicine News talked to eight scientists and clinicians who will be researching and caring for patients in the new EMU at the Pavilion to preview how the facility can help transform their research today into the research of tomorrow.
Penn Medicine researchers have developed a new targeted approach to prevent a toxicity seen in the sensory neurons of dorsal root ganglia after gene therapy to treat neurological disorders.
While the number of new COVID-19 hospitalizations continue to decline in Pennsylvania and New Jersey, the pandemic is intensifying in some southern and western states.
Penn Medicine News